These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The short-circuit evidence on lipid-lowering drugs use in pregnancy. Fogacci F; Borghi C; Cicero AFG Atherosclerosis; 2023 Mar; 368():12-13. PubMed ID: 36754660 [No Abstract] [Full Text] [Related]
5. RE.: Impact of long-term lipid-lowering therapy on clinical outcomes in breast cancer. Harborg S; Cronin-Fenton DP; Borgquist S Breast Cancer Res Treat; 2019 Oct; 177(3):771-772. PubMed ID: 31270762 [No Abstract] [Full Text] [Related]
6. More Nuanced Guidelines for Lipid Lowering to Prevent CVD. Shaughnessy AF Am Fam Physician; 2016 Jan; 93(1):59. PubMed ID: 26760843 [No Abstract] [Full Text] [Related]
8. Clinical Outcomes in Trials Evaluating Lipid-Lowering Drugs. Butters J; Brown A; Griffith L; Kim S; Nicholls SJ Am J Cardiovasc Drugs; 2017 Dec; 17(6):447-452. PubMed ID: 28432573 [TBL] [Abstract][Full Text] [Related]
9. Nutraceuticals in lipid-lowering treatment: a narrative review on the role of chitosan. Patti AM; Katsiki N; Nikolic D; Al-Rasadi K; Rizzo M Angiology; 2015 May; 66(5):416-21. PubMed ID: 25037700 [TBL] [Abstract][Full Text] [Related]
10. Results of the REVEAL study. Why Should we not welcome a new lipid lowering agent? Masana L Clin Investig Arterioscler; 2017; 29(6):278-279. PubMed ID: 29173491 [No Abstract] [Full Text] [Related]
11. Design and rationale for the Patient and Provider Assessment of Lipid Management (PALM) registry. Navar AM; Wang TY; Goldberg AC; Robinson JG; Roger VL; Wilson PF; Virani SS; Elassal J; Lee LV; Webb LE; Peterson E Am Heart J; 2015 Nov; 170(5):865-71. PubMed ID: 26542493 [TBL] [Abstract][Full Text] [Related]
12. Lipid Metabolism and Emerging Targets for Lipid-Lowering Therapy. Gaudet D; Drouin-Chartier JP; Couture P Can J Cardiol; 2017 Jul; 33(7):872-882. PubMed ID: 28365054 [TBL] [Abstract][Full Text] [Related]
13. Nicotinic acid: current status in lipid management and cardiovascular disease prevention. Whayne TF Angiology; 2014 Aug; 65(7):557-9. PubMed ID: 24101713 [No Abstract] [Full Text] [Related]
14. Statins in coronary artery bypass grafting surgery: lipid lowering and beyond. Margaritis M; Antoniades C Expert Rev Cardiovasc Ther; 2012 Jan; 10(1):5-8. PubMed ID: 22149521 [No Abstract] [Full Text] [Related]
15. Preventing cardiovascular outcome in patients with renal impairment: is there a role for lipid-lowering therapy? Holdaas H Am J Cardiovasc Drugs; 2005; 5(4):255-69. PubMed ID: 15984908 [TBL] [Abstract][Full Text] [Related]
16. A Systematic Review of Cardiovascular Outcomes-Based Cost-Effectiveness Analyses of Lipid-Lowering Therapies. Wei CY; Quek RGW; Villa G; Gandra SR; Forbes CA; Ryder S; Armstrong N; Deshpande S; Duffy S; Kleijnen J; Lindgren P Pharmacoeconomics; 2017 Mar; 35(3):297-318. PubMed ID: 27785772 [TBL] [Abstract][Full Text] [Related]